D iverticular bleeding is the most frequent etiology of acute lower gastrointestinal bleeding (LGIB), a condition that is associated with significant medical resource utilization. 1, 2 Colonoscopy has a diagnostic and therapeutic role in LGIB and is recommended within 24 hours of admission by the American Society of Gastrointestinal Endoscopy after diagnostic esophagogastroduodenoscopy in patients with severe hematochezia. 3 However, the evidence supporting this statement is of moderate quality. Although Jensen et al 4 showed that early colonoscopy in the setting of severe hematochezia and diverticulosis allowed for increased endoscopic therapy and a decreased need for surgery, subsequent studies remain conflicted regarding the diagnostic and therapeutic utility of early colonoscopy. Recent metaanalyses of urgent colonoscopy in LGIB have shown that early colonoscopy is associated with higher rates of endoscopic intervention, however, it is not associated with improvement in important clinical outcomes such as rebleeding, surgery, and mortality. 5, 6 Thus, this management strategy has not been widely adopted as the standard of care at many hospitals.
Moreover, there are limited data on the performance of early colonoscopy in acute diverticular bleeding, and whether this impacts postdischarge hospital outcomes such as recurrence of bleeding and hospital re-admissions. This outcome is increasingly relevant given the significant health care burden of LGIB. 7 Given the increasing age of our population, increased incidence of diverticular bleeding in the elderly, and high risk of recurrent diverticular bleeding, there is an unmet need for real-world data to guide clinicians regarding optimal timing of colonoscopy in the setting of colonic diverticular bleeding. 1, 8 Our primary aim was to determine whether early colonoscopy was associated with decreased 30-day rebleeding and 30-day re-admissions. Our secondary aims were to describe additional clinical factors associated with these postdischarge adverse outcomes.
Methods

Patients
We performed a retrospective cohort study using medical claims from the Truven Health Marketscan Commercial Claims and Encounters Database (Truven Health Analytics, Inc, Ann Arbor, MI) from January 1, 2004, through September 27, 2015. The Marketscan databases record enrollment information and health insurance claims from inpatient and outpatient services. Patient enrollment data are linked to medical and outpatient prescription drug claims and encounter data, allowing individual-specific clinical utilization, and outcomes for inpatient and outpatient services.
We included adult patients older than 18 years of age with a primary diagnosis of diverticular bleeding (International Classification of Diseases, 9th revision [ICD-9] code 562.12) who underwent colonoscopy during hospitalization. Information during index hospitalization was collected and included demographics and medication use (including anticoagulant and antiplatelet drugs). Anticoagulant medications recorded were apixaban, dabigatran, rivaroxaban, and warfarin. Thienopyridine medications recorded were clopidogrel, prasugrel, ticagrelor, and ticlopidine. Comorbidities were defined using inpatient and outpatient claims submitted 3 to 12 months before index hospitalization. Performance of colonoscopy was defined by Current Procedural Terminology (CPT) codes (44388-44393, 45378, 45380, and 45382-45385). Colonoscopy with intervention was defined by the CPT code 45382. We excluded patients who had their colonoscopy before their hospitalization.
We also recorded other details of in-hospital management including performance of radiologic studies (computed tomography angiography, direct angiography), packed red blood transfusion, fresh-frozen plasma transfusion, intensive care unit (ICU), need for surgery, and length of stay. Postdischarge outcomes recorded were rebleeding and all-cause re-admission events within 30 days of discharge after index hospitalization. Rebleeding was defined as a claim for re-admission to any hospital within 30 days because of recurrent GIB defined by a primary ICD-9 discharge diagnosis of GIB (Supplementary Table 1) . We used an expanded definition for rebleeding (including upper and lower GIB) to capture all bleeding events requiring hospitalization (including recurrent diverticular bleeding, ICD-9 code 562.12) after index hospitalization because we believed these events were clinically significant and likely related to the index LGIB. All patient information was de-identified and Health Insurance Portability and Accountability Act compliant and was considered exempt from review by the University of Chicago Institutional Review Board. Supplementary Table 1 shows the ICD-9 codes used to define comorbidities, GIB, and the list of CPT codes used.
Statistical Analysis
We assigned all patients to 1 of 2 groups based on the timing of colonoscopy during admission: early colonoscopy was defined as occurring on the same day as admission vs delayed colonoscopy, which was defined as occurring after day 0 of hospitalization. The precise time in hours to performance of colonoscopy was unavailable in the data set. We used propensity score matching to adjust for differences between patients who underwent early colonoscopy vs delayed colonoscopy. To construct the propensity score, we used a logistic regression model for the recipient of early colonoscopy as a function of the following variables: age, comorbidities
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(coronary artery disease, hypertension, congestive heart failure, ischemic stroke, venous thromboembolism, and end-stage renal disease), medications (anticoagulant and thienopyridine use), in-hospital management (packed red blood transfusion, fresh-frozen plasma transfusion, ICU care), and prior history of diverticulosis and gastrointestinal bleeding. Several of these variables were significantly different between the early and delayed colonoscopy groups. We performed 1-to-1 propensity matching analysis between early and delayed colonoscopy groups by using the nearest-neighbor method. Each individual with an early colonoscopy was matched to a patient with delayed colonoscopy whose propensity score was closest to that of early colonoscopy. If multiple patients in the delayed colonoscopy group were equally close to the patient with an early colonoscopy, then 1 of them was selected at random.
We compared the matched groups on demographics, health, and treatment. Categoric variables were reported as percentages to describe proportions and continuous variables were reported as medians (interquartile ranges) or as otherwise indicated. Comparisons between groups for categoric data were made using Fisher exact tests. Continuous data were compared using 2-sample t tests for normally distributed variables and Wilcoxon rank sum tests for non-normally distributed variables.
Multivariable logistic regression was used to determine the association between early colonoscopy and other admission variables with 30-day rebleeding and 30-day all cause re-admissions. All the analyses were performed using JMP 12.2.0 software (SAS Institute, Inc, Cary, NC).
Results
Patient Characteristics
A total of 20,010 patients were identified who underwent colonoscopy for diverticular bleeding during the index hospitalization. Of these patients, 11,690 (58%) underwent early colonoscopy and 8320 (42%) had a delayed colonoscopy. The median time to colonoscopy in the delayed colonoscopy group was 2 days. The median age of the study cohort was 76 years (interquartile range [IQR], 64-83) and 55% were men. Included patients were from the northeast, north central, southern, and western regions of the United States. Most patients were enrolled in a comprehensive or preferred provider organization plan. The overall frequency of 30-day rebleeding events was 2% (n ¼ 420) and 30-day re-admissions was 4% (n ¼ 868). A prior history of diverticulosis was recorded in 143 (0.71%) patients, and diverticular bleeding in 98 (0.5%) patients. The median hospital length of stay was 3 days (IQR, 2-5 d) in the cohort. No patients died during the index hospitalization. The median gross payment to all providers who submitted claims for covered services rendered during an admission was $7522.25. Patients who underwent an early colonoscopy were less likely to have coronary artery disease (21% vs 23%; P < .0001), congestive heart failure (12% vs 14%; P < .0001), and venous thromboembolism (3% vs 4%; P ¼ .003). A lower proportion of the early colonoscopy group was taking anticoagulant medication (12% vs 14%; P < .001) and thienopyridines (12% vs 14%; P < .0001) before admission. Table 1 shows the comparison of variables between the early vs delayed colonoscopy groups.
After 1-to-1 propensity score matching, 8320 pairs of early and delayed colonoscopy patients were selected. No significant differences were observed in demographics, comorbidities, medication use, radiologic studies, transfusion requirements, or need for ICU care after matching (Table 1 ). In the group of patients that underwent multiple colonoscopies (n ¼ 6419), 2% (n ¼ 190) underwent intervention during initial colonoscopy and 95% (n ¼ 6112) underwent intervention during subsequent colonoscopies. Patients who had early colonoscopy underwent more colonoscopies (73% vs 4%; P < .0001), but fewer endoscopic interventions (3% vs 8%; P < .0001), and had a shorter length of stay (3 days [IQR, 2-4] vs 3 days [IQR, 2-5]; P < .0001). The median total net payments for the admission in the early colonoscopy group ($7295.91) was significantly lower than that of the delayed colonoscopy group ($7690.13) (P < .0001). A higher portion of the early colonoscopy group experienced 30-day rebleeding (2% vs 1.6%; P ¼ .03). Table 2 shows the comparison of additional clinical outcomes between the matched early vs delayed colonoscopy groups.
Risk Factors Associated With 30-Day Rebleeding
Two percent (n ¼ 308 of 16,640) of patients had recurrent bleeding within 30 days. The median time to hospitalization for rebleeding was 12 days. The most common reasons for hospital re-admission after the index diverticular bleed were recurrent diverticular bleeding (ICD-9 code 562.12) (n ¼ 172), hemorrhage of the gastrointestinal tract, unspecified (ICD-9 code 578.9) (n ¼ 54), and melena (ICD-9 code 578.1) (n ¼ 24). A multivariable logistic regression model was constructed adjusting for age, coronary artery disease, chronic kidney disease, admission anticoagulant use, admission thienopyridine use, transfusion requirement, early colonoscopy, and colonoscopy with intervention. Early colonoscopy (odds ratio [OR], 1.34; CI, 1.08-1.66; P ¼ .007), chronic kidney disease (OR, 2.13; CI, 1.49-3.04; P < .0001), and blood transfusion requirement during the index hospitalization (OR, 2.31; CI, 1.88-2.83; P < .0001) were associated with an increased risk of 30-day rebleeding. Admission anticoagulant use (OR, 0.64; CI, 0.44-0.94; P ¼ .02) was associated with a decreased risk of 30-day rebleeding. Table 3 shows the Prior history of any GI Bleeding, diverticulosis, or diverticular bleeding were defined by any claims submitted for the respective conditions defined by ICD-9 codes during the 3-to 12-month period before the index hospitalization for diverticular bleeding.
additional variables associated with 30-day rebleeding on multivariate regression.
Risk Factors Associated With 30-Day Readmission
Four percent (n ¼ 665 of 16,640) of patients were readmitted to the hospital for any cause within 30 days. The median time to all-cause re-admission was 6 days. The most common reason for 30-day re-admission was recurrent bleeding (n ¼ 250). The next most common reason for hospital re-admission was congestive heart failure, unspecified (ICD-9 code 428.0) (n ¼ 14). A multivariable logistic regression model was constructed adjusting for age, coronary artery disease, chronic kidney disease, admission anticoagulant use, admission thienopyridine use, transfusion requirement, early colonoscopy, and colonoscopy with intervention. Early colonoscopy (OR, 1.18; CI, 1.02-1.36; P ¼ .03), colonoscopy with intervention (OR, 1.37; CI, 1.03-1.81; P ¼ .03), coronary artery disease (OR, 1.27; CI, 1.06-1.51; P ¼ .009), chronic kidney disease (OR, 1.98; CI, 1.54-2.54; P < .0001), and blood transfusion requirement (OR, 2.17; CI, 1.88-2.51; P < .0001) were associated with an increased risk of 30-day re-admissions. Table 4 shows the additional variables associated with 30-day re-admission.
Discussion
In this large retrospective study using a national insurance claims database, we sought to compare whether performance of early vs delayed colonoscopy in acute diverticular bleeding impacted postdischarge outcomes, specifically in regard to 30-day rebleeding events and all-cause re-admissions. In our matched propensity score analysis, early colonoscopy in the setting of diverticular bleeding was associated with both an increase in 30-day rebleeding and all-cause re-admissions.
Our findings showing a lack of benefit in postdischarge outcomes with early colonoscopy after adjusting for confounding variables both confirm and extend previous findings reporting a limited benefit of early colonoscopy in LGIB. Two prior studies by Laine et al 9 and Green et al 10 showed no reduction in rebleeding events with early colonoscopy. In a recent propensity-matched analysis, Nagata et al 11 showed that despite an increased rate of detecting sources of bleeding and endoscopic therapy with early colonoscopy, there was no improvement in mortality or blood transfusion requirement. Interestingly, the investigators noted a trend toward increased risk of 30-day rebleeding, although it did not reach statistical significance.
In our large study on postdischarge outcomes of patients undergoing colonoscopy for diverticular bleeding, we show that early colonoscopy is associated with a higher risk of 30-day rebleeding. We believe these results may be owing, in part, to significantly fewer endoscopic interventions being performed in recipients of early colonoscopy. This decreased intervention rate is different from the aforementioned studies, 11 as well as results from our previously published work. 12 There are a few potential explanations for this finding. First, the lack of interventions in early colonoscopy may be representative of real-world management of diverticular bleeding because our data set is a national representative sample. Prior studies showing increased endoscopic interventions and reduced rebleeding with early colonoscopy have been performed primarily in tertiary care academic medical centers, often with specialized bleeding teams that may have greater expertise in treating patients with acute LGIB. Second, early colonoscopy may be performed at the expense of complete bowel preparation, thus leading to poor visualization and reduced endoscopic interventions. Unfortunately, data on preparation quality were unavailable in the database.
Another potential explanation for the increased risk of 30-day rebleeding and all-cause re-admission events in the early colonoscopy group is that patients undergoing early colonoscopy may have represented a sicker population with more clinically significant bleeding, and thus were at a higher risk of recurrent bleeding after discharge, independent of performance of colonoscopy and intervention. However, we believe this is less likely because the early group had similar comorbidities and rates of blood transfusion and ICU care, along with lower frequency of anticoagulant and thienopyridine use. Moreover, we used propensity matching to account for differences in patients undergoing early vs delayed colonoscopy, thereby increasing the validity of our findings. We recognize the risks of residual confounding in the analysis, particularly given that data such as the presence of shock, vital signs, and hemoglobin levels were not available given the nature of the claims database. Regardless, we believe our data provide a stark assessment that early colonoscopy does not alter the natural history of patients with diverticular bleeding, and in fact may subject patients to worsened outcomes owing to fewer interventions.
Performance of early colonoscopy was associated with a shorter length of stay during the index hospitalization, a benefit that has been stressed by proponents of the strategy to undergo early colonoscopy in LGIB. Importantly, we show that this up-front reduction in hospitalization cost must be balanced against the increased risk for re-admission because of recurrent bleeding. This slight reduction in length of stay also was observed in prior studies examining the role of early colonoscopy in patients with acute LGIB. 11, 12 These findings also were observed in a larger cross-sectional study using the Nationwide Inpatient Sample database. 13 Although the early colonoscopy group underwent fewer endoscopic interventions, it is plausible that this allowed identification of select low-risk patients in whom the initial diverticular bleed had resolved spontaneously and, thus, facilitated earlier discharge. Cost-effective analysis studies are needed to weigh the cost benefits of reduced length of stay vs the potential increased risk of hospital re-admissions.
Strengths of our study included the fact that we described the outcomes of a large population of patients with diverticular bleeding. We provide real-world, generalizable data on the effect of timing of colonoscopy and other clinical factors with 30-day rebleeding and 30-day re-admission rates in the United States. Furthermore, we were able to capture patients re-admitted to another facility because our data set included patients continuously enrolled in the insurance program.
These data should be interpreted in the context of study design. Given the limitations of an insurance claims database, we may not have captured all follow-up rebleeding and re-admission events, especially if claims were either not submitted or were delayed beyond 30 days in the insurance program. Our definition of early vs delayed colonoscopy was based on the day of admission because we did not have the number of hours to colonoscopy. Thus, misclassification of patients in the early vs delayed colonoscopy group was possible. However, we believe that this is unlikely to have altered our results. As mentioned previously, data on vital signs and laboratory values at admission were unavailable in the data set. The Marketscan database also does not capture occurrence and timing of mortality events. Thus, we were unable to determine whether early colonoscopy was associated with improved mortality in the setting of diverticular bleeding. Furthermore, the source of bleeding during the index hospitalization was determined per billing codes and could not be confirmed with a manual review of endoscopy reports. However, we accounted for this by selecting only patients who had a primary discharge diagnosis of diverticular bleeding based on one ICD-9 code. Although a reduction in 30-day rebleeding events was observed for patients on anticoagulants and/or thienopyridines at admission, details of inpatient and postdischarge management of these medications were not available. Thus, further studies are needed to determine the optimal management of anticoagulants and thienopyridines in patients with diverticular bleeding. The overall number of patients requiring surgery was low and, given that the indication for and timing of surgery after initial or recurrent bleeding were not available, we were unable to assess the impact of surgery on postdischarge outcomes. Although esophagogastroduodenoscopy was performed more frequently among patients receiving delayed colonoscopy, not knowing the timing of the procedure in relation to colonoscopy precluded assessing its role in the management of these patients. Regardless, we believe that esophagogastroduodenoscopy should be performed in all patients with severe hematochezia according to current guidelines. 2 We also did not capture patients admitted for observational stays or discharged from the emergency department. Future studies are needed to evaluate postdischarge adverse outcomes in low-risk patients with gastrointestinal bleeding. Finally, given the retrospective nature of our findings, further prospective studies are needed to determine the optimal timing of colonoscopy in the setting of diverticular bleeding with respect to rates of interventions and 30-day rebleeding events.
In conclusion, in our propensity-matched analysis, we show that early colonoscopy may not alter the natural course of patients with diverticular bleeding with respect to 30-day rebleeding events and re-admissions.
